JAMDA
July 6, 2018
Showing 1681 - 1690 of 7199 results
JAMDA
April 28, 2023
Corrigendum
JAMDA
April 28, 2023
Corrigendum
JAMDA
August 27, 2022
Corrigendum
JAMDA
April 24, 2024
Corrigendum
JAMDA
February 20, 2019
Cosas de la Edad, a Therapeutic Intergenerational Experience
JAMDA
February 15, 2019
Cost Benefit of High-Dose vs Standard-Dose Influenza Vaccine in a Long-Term Care Population During an A/H1N1-Predominant Influenza Season
Influenza is a leading cause of admissions for nursing home (NH) residents. We previously evaluated the effectiveness of a high-dose trivalent influenza vaccine (HD) compared to a standard-dose influenza vaccine (SD) through a cluster-randomized trial of NH residents. Fewer residents from facilities rando...
JAMDA
January 30, 2024
Cost-Consequence Analysis of Deprescribing to Optimize Health Outcomes for Frail Older People: A Within-Trial Analysis
The structured, clinically supervised withdrawal of medicines, known as deprescribing, is one strategy to address inappropriate polypharmacy. This study aimed to evaluate the costs and consequences of deprescribing in frail older people living in residential aged care facilities (RACFs) in Australia. ...
JAMDA
June 27, 2024
Cost-Consequence Analysis of Deprescribing to Optimize Health Outcomes for Frail Older People: A Within-Trial Analysis
JAMDA
February 3, 2021